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Abstract  5 
Background: The use of sterile water injections (SWI) for the relief of pain in labour is popular 6 
amongst midwives in countries such as Sweden and Australia. Anecdotal reports suggest the 7 
procedure is used less commonly in the United Kingdom (UK) and that a number of barriers to 8 
introducing the practice may exist. 9 
Objective: The objective of this study was to explore the awareness and use of SWI amongst 10 
midwives in the UK. 11 
Design: A cross sectional study using an internet-based questionnaire.  12 
Participants: Midwives with Nursing and Midwifery Council Registration and currently practicing. 13 
Setting: The questionnaire was distributed via the Royal College of Midwives Facebook page and 14 
Twitter account. Invitations to participate were also sent to Heads of Midwifery to distribute to staff. 15 
Findings: Three hundred and ninety eight midwives completed the survey. Eighty-two percent of 16 
midwives did not use SWI in practice although 69% would consider learning the procedure. There 17 
was considerable variation in techniques amongst midwives that did provide SWI. The lack of 18 
available practice guidelines and the advice from the National Institute for Health and Care 19 
Excellence to not use SWI were cited as the main barriers.  20 
Key Conclusions: SWI use is uncommon in the UK although midwives are interested in incorporating 21 
the procedure into practice.  22 
Implications for practice: National guidance on SWI and the lack of information and training is 23 
restricting the use of the procedure in practice, despite SWI being widely used in other countries and 24 
being effective in the treatment of pain in labour.   25 
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Background  27 
Up to 75% of women may experience back pain during labour with 30-45% reporting the pain as 28 
both continuous and severe (Melzack & Schaffeberg, 1987; Tzeng & Su, 2008). In a qualitative study 29 
of labouring women’s experiences of back pain, participants described the sensation as crushing and 30 
stated the level of intensity limited their mobility and altered their plans for pain relief (Lee et al., 31 
2015). Back pain is more common in nulliparous women and associated with the latent phase of first 32 
stage labour (prior to four centimetres of cervical dilation) (Lee et al., 2013). The intensity of the pain 33 
may increase as the labour progresses and early intervention is recommended (Tzeng & Su, 2008).  34 
Managing back pain in labour and the administration of SWI 35 
The literature identifies three non-pharmacological strategies that may be used specifically for the 36 
treatment of back pain in labour: acupuncture, transcutaneous nerve stimulation (TENS) and sterile 37 
water injections (SWI) (Labrecque et al., 1999; Martensson et al., 2008). Of the three, SWI has been 38 
demonstrated to be more effective than either acupuncture (Martensson & Wallin, 1999), TENS or 39 
more general non-pharmacological approaches such as massage or water immersion (Labrecque et 40 
al., 1999). SWI involves the injection of between 0.1 and 0.5 millilitres (mls) of sterile water into the 41 
intradermal or subcutaneous layers of the skin surrounding the lumber region (Michaelis Rhomboid) 42 
of the lower back (Mårtensson et al., 2017). The injections results in a brief but intensely painful 43 
sensation followed rapidly by the onset of analgesia which can last for up to two hours; it may be 44 
repeated as many times as required (Martensson & Wallin, 2008b). It is theorised that the brief 45 
episode of noxious stimulus triggers the body’s own pain modulating systems such as the gate 46 
control theory, where intense stimulations of competing nerve fibres result in a diminished 47 
perception of pain from the slower visceral fibres associated with back pain (Melzack & Wall, 1965). 48 
The release of endorphins similar to those demonstrated in Diffuse Noxious Inhibitory Controls may 49 
also contribute to the analgesia experienced (Le Bars et al., 1992).  50 
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Whilst previous systematic reviews and meta-analysis have highlighted the potential of SWI to 51 
provide a safe, effective and low technology analgesic option that is suitable for all maternity care 52 
settings and models of care (Hutton et al., 2009; Martensson & Wallin, 2008b), the 2012 Cochrane 53 
review identified potential issues with the existing evidence and recommends further research to 54 
report more clinically relevant outcomes (Derry, Straube, Moore, Hancock & Collins). SWI is 55 
frequently used in Scandinavian countries such as Sweden (Martensson & Wallin, 2006) and is 56 
becoming increasingly popular amongst midwives in Australia (Lee et al., 2012). However, there is no 57 
data regarding the utilisation of SWI by midwives in the United Kingdom (UK), the extent of 58 
awareness of the procedure, availability, clinical application or techniques used. The first author has 59 
provided assistance to a number of maternity units in the UK in the form of information, training 60 
materials and support for clinical governance processes. Some of these maternity units have 61 
reported difficulties in introducing SWI due to the very limited availability of information within NHS 62 
Maternity Units and resistance from clinical leaders unfamiliar with the procedure. A contributing 63 
factor may also be the lack of support for SWI in the National Institute for Health and Care 64 
Excellence (NICE): Intrapartum Care guidelines (2014). However, there is no specific data available 65 
on the challenges and barriers encountered by practitioners within the UK wanting to introduce SWI. 66 
Methods  67 
Study Aim and Design 68 
The aim of this study was to describe the knowledge and practice of SWI by UK midwives. The study 69 
employed a cross-sectional design via an electronic, internet based survey, adapted from similar 70 
surveys conducted in Australia (Lee et al., 2012), Sweden (Martensson & Wallin, 2006) and the USA 71 
(Martensson et al., 2008a). The survey was organised into three distinct parts. The first section 72 
contained 10 questions collecting demographic data such as age, original midwifery qualification, 73 
main area of clinical practice and geographic location. This part was to be completed by all 74 
respondents. Then respondents were directed to one of two sections of the survey depending on 75 
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their response (yes or no) to a question regarding their current use of SWI in practice. Those 76 
answering ‘No’ then completed 11 questions regarding their level of knowledge of SWI, whether 77 
they would consider its use in practice, preferences for training and information, what barriers they 78 
may or had encountered regarding the introduction of SWI to their workplace and their current 79 
management strategies for back pain in labour. Those respondents that indicate current use of SWI 80 
were directed to 15 questions regarding use in practice, effectiveness, variations in injection 81 
techniques and information supplied to women. Both the latter two sections contained free text 82 
areas in some questions for participants to respond with their own experiences and opinions.  83 
Survey Distribution and Participants 84 
We were aiming to reach practicing midwives in the UK (England, Wales, Scotland and Northern 85 
Ireland) with current Nursing and Midwifery Council Registration.  As the largest professional 86 
representative organisation for midwifery in the UK the researchers negotiated with the Royal 87 
College of Midwives (RCM) to distribute an electronic link for the survey to the membership. The 88 
usual approach by the RCM was to offer research surveys to a random sample of 1000 midwives on 89 
the RCM membership email list, however this was not available due to a change in RCM policy 90 
governing distribution of external surveys, so an invitation to participate in the survey including the 91 
survey internet address was published in the Letters page of the RCM Midwifery Magazine. This 92 
approach resulted in only six completed surveys. An invitation to participate and an electronic link to 93 
the survey was then posted on the RCM Facebook page (approximately 41,000 followers) and 94 
distributed via the RCM Twitter account approx. 29,700 followers). The tweet included a request to 95 
retweet (RT) to assist in distribution. Two reminder tweets were sent during the following seven 96 
days. At the same time an email containing a link to the survey and an invitation to participate was 97 
sent to a number of maternity units (n=156) via the Heads of Midwifery network with a request to 98 
distribute to midwifery staff. We have no way of knowing how many people received this invitation 99 
or viewed the Facebook and twitter posts.   100 
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Ethical and Governance issues 101 
The introductory page of the survey detailed the purpose of the study, the inclusion criteria, and the 102 
voluntary nature of participation. However, there was no process for confirming if respondents met 103 
the inclusion criteria. There was no formal consent process required, it was considered that if 104 
potential respondents followed the link from the introduction to the commencement of the survey 105 
this implied an acceptance of the invitation to participate. Ethics approval for the survey was 106 
provided by the University of Hull; Faculty of Health and Social Care Research Ethics Committee (Ref. 107 
192) and the University of Queensland Human Research Ethics Committee (2015001182). As this 108 
low-risk study was a collaboration between researchers at the University of Hull, University of 109 
Queensland and Mater Research Institute a three party collaborative research contract with 110 
agreement on study indemnity was required, this process took over 12 months to complete.   111 
Sample size and Data analysis  112 
At the time the survey was undertaken the number of midwives registered with the NMC was 113 
estimated to be 43,168 including those with both Midwifery and Nursing and/or Specialist 114 
Community Public Health Nurses registration. For a representative sample with 95% confidence level 115 
and 5% margin of error a total of 381 surveys would be required. Data were analysed using Stata 116 
statistical software (StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: 117 
StataCorp LP). Descriptive statistics were calculated for all variables including percentages, mean, 118 
standard deviation, median and range as appropriate. Where missing data occurred due to 119 
participants not responding to all questions in the survey, percentages for the actual number of 120 
respondents are given. A simple content analysis categorised responses to the open-ended 121 
questions.  122 
Findings 123 
Three hundred and ninety eight midwives undertook the survey. A further 23 supplied only 124 
demographic data, not responding to the question regarding SWI use, their data were not included 125 
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in the analysis. Demographic data is presented in Table 1. The majority of respondents were 126 
Bachelor of Midwifery graduates (66.2%) and 245 (61.5%) indicated they provided care to women 127 
during labour and birth as a regular part of their practice (Table 2).  128 
Midwives who use SWI  129 
Seventy two (18.0%) midwives responding to the survey used SWI in practice whilst 327 (82.0%) did 130 
not. Midwives using SWI tended to be younger, aged between 20 and 50 years compared to those 131 
51 years and over.  By far England had the most number of midwives using SWI (91.4%), with no 132 
midwives in Wales reporting use of the procedure (Table 2). The Southeast of England reported the 133 
most midwives using SWI (43.0%) with the East Midlands reporting the least (1.6%).  Almost the 134 
same number of midwives from tertiary maternity units used SWI (n=34) as those working in district 135 
towns (n=37) (Table 2) 136 
 137 
Not unsurprisingly most midwives using SWI worked in a birth setting such as a labour ward (n=42) 138 
or Birth Centre (n=12), although midwives working in antenatal / postnatal settings also reported 139 
use (n=11) However 29.8% (23/78) also reported encountering resistance to using SWI from 140 
midwifery or medical colleagues. Just over half (27/51, 52.9%) indicated they administered SWI 141 
frequently or very frequently. All midwives used SWI to relieve back pain, whilst 10% (6/60) also 142 
used the procedure for abdominal pain. Participants were asked about the effectiveness of SWI as 143 
an analgesic with most (85.9%) indicating they considered SWI to be ‘very effective or moderately 144 
effective, and 14% as not very or rarely effective.  Although fewer midwives (79.2%) considered SWI 145 
to be very reliable or moderately reliable and 20.7% as not very or unreliable (Table 3). Midwives 146 
also ranked in order of preference the non-pharmacological methods to relieve back pain offered to 147 
women. SWI was ranked fourth behind water immersion, massage and transcutaneous nerve 148 
stimulation (TENS), but ahead of hot packs, aromatherapy, showers and acupuncture.  149 
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The survey contained a number of questions regarding techniques used to administer SWI. 150 
Respondents were evenly divided (50%/50%, n=52) between the use of either the intradermal or 151 
subcutaneous route. However the amount of sterile water used for each individual injection varied 152 
between 0.1 – 0.5 ml regardless of the preferred technique. Midwives using the intradermal 153 
technique, compared to the subcutaneous administration, were more likely to rate SWI as very 154 
effective (21/47, 44.6% vs 14/47, 29.7%) and very reliable (21/47, 44.6% vs 12/47, 25.5%). Four 155 
injections were most commonly provided (40/46, 86.9%), four) midwives (4/46, 8.7%) indicated they 156 
gave two injections and a single injection was used by only two (2/46, 4.3%).) respondents. Fifty-157 
three percent (25/47) of midwives gave the injections during a contraction with the remainder 158 
(22/47, 46.8%) administering the injections between contractions.  159 
Midwives who do not use SWI. 160 
Almost half (49.6% 149/300) of the midwives who indicated that they do not use SWI were also 161 
unaware of the procedure as a means of pain relief in labour, this was also reflected in the free text 162 
responses (7/16). Of the 151 midwives who had knowledge of SWI 33.8% (51/151) learnt about it 163 
from reading a journal article, 27.2% (41/151) from a colleague whereas 11.9% (18/151) had 164 
received the information at a conference or study day. Eighteen respondents (11.9%) had learnt 165 
about SWI during their midwifery training, seven (4.6%) whilst employed at another hospital, seven 166 
(4.6%) from an online source such as a midwifery forum, five (3.3%) from other sources such as own 167 
dissertation studies, three respondents did not provide a source. Of the 20 midwives responding to 168 
the free text option in this section, four (20%) midwives did indicate that the procedure had been 169 
withdrawn from practice at their hospitals: 170 
“Used to use them in practice. Head of midwifery stopped us.” 171 
“We were taken over by a different trust who did not use SWI and even though we had been supplied 172 
with all the research they stopped us from using it until further research was carried out”. 173 
8 
 
©2018 This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Whilst 69.3% (205/296) of midwives would consider using SWI in practice the remaining 30.7% 174 
(91/296) would not. The most common reasons for not using SWI in practice was a lack of support 175 
from institution (18.9% 17/90) and the absence of a protocol or guideline (17.8% 16/90). A lack of 176 
confidence using the procedure was cited by 14.4% (13/90), and 13.3% (12/90) due to a perceived 177 
lack of supporting evidence. In the free text responses 31% (5/16) of participants questioned if the 178 
procedure had a placebo effect and was therefore unethical: 179 
“It would be wrong to pretend to give pain relief but only give water” 180 
Whilst others were not supportive of the use of the procedure: 181 
“Barbaric! It might work, but at what cost. Horrendous practice - where is the push for one to one 182 
care, education and kindness towards women which could help them cope better? Let's just stab 183 
them ANOTHER needle. Abhorrent practice”. 184 
Of the midwives who would consider using SWI 74% (151/203) indicated that a lack of supporting 185 
policy and guidelines was the main barrier to implementation, with a number citing the advice 186 
provided by the National Institute for Health and Care excellence (NICE) to not offer women SWI as a 187 
significant contributing factor. Not being able to access education materials and training was cited 188 
by 10.9% (22/203) and only 1.9% (4/203) stated that resistance from midwifery or medical 189 
colleagues contributed to preventing the implementation of SWI. However only nine midwives (3%) 190 
reported that their place of work was in the process of introducing SWI with only two respondents 191 
indicating this was at the inservice training stage.  192 
The majority of midwives not currently using SWI indicated they would like more information about 193 
the procedure (86%, 258/300). Information presented in an online resource was ranked as the 194 
preferred option followed by workshops, printed resources and a smartphone application.  195 
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From a practice perspective, midwives not using SWI also ranked water immersion, massage and 196 
TENS as preferred options for treating back pain in labour, followed by showers, hotpacks, 197 
aromatherapy and acupuncture.  198 
Discussion 199 
To our knowledge this is the first UK wide survey of midwives use of SWI. The results do suggest that 200 
the use of SWI in the UK (18%) is far less than that reported in similar surveys from Sweden (91%) 201 
(Martensson & Wallin, 2006), the USA (32%) (Martensson et al., 2008a) or Australia (42%) (Lee et al., 202 
2012). This may be the consequence of a lack of support for SWI in the NICE: Intrapartum Care 203 
guidelines (2014) as suggested by a number of the respondents. The UK NICE guidelines on 204 
Intrapartum Care: care of healthy women and their babies during childbirth, is a prominent source of 205 
evidenced based recommendations for clinical practice. The section of the guidelines concerning 206 
SWI has not been updated since 2007 when it included two systematic reviews (Huntley et al., 2004; 207 
Simkin & Bolding, 2004) to inform their recommendations. Both systematic reviews included the 208 
same four trials involving 451 women and both reviews concluded that SWI significantly reduced 209 
back pain for 60 to 90 minutes in up to 90% of the women receiving the treatment. Since 2007 two 210 
systematic reviews (6 trials )  (Fogarty, 2008; Martensson & Wallin, 2008b) and a meta-analysis (8 211 
trials n=828) (Hutton et al., 2009) have been published that reported a significant reduction in 212 
subjective pain measurements in all reviewed randomised controlled trials. A Cochrane review by 213 
Derry et al (2012) (7 trials, n=766) cited previous work by Moore et al (2005) to use a percentage 214 
reduction (50% and 30%) in post treatment pain scores as a more clinically relevant benchmark to 215 
conduct the review. However as no previous trials had reported in this criteria they concluded that 216 
further research was required. A RCT comparing a single to four injections of sterile water in labour 217 
(Lee et al., 2013) did report using the criteria recommended by Derry et al (2012) and found that at 218 
30 minutes post treatment 87% of participants receiving four injections reported at least a 30% 219 
reduction in pain, and 72.8% reported at least a 50% reduction.  220 
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In 2007 the NICE guidelines on Intrapartum Care (. National Institute for Health and Care Excellence, 221 
2007) advised that “The use of injected water papules is not recommended” (Section 5.3.5, p97). In 222 
the 2014 edition (. National Institute for Health and Care Excellence) it was stated that the section 223 
on SWI, referred to as ‘injected water papules’ had not been reviewed and therefore, in terms of 224 
evidence, remained unchanged from 2007, however the recommendation had been changed from 225 
‘not recommended’ to “Do not use injected water papules” (section 8.3.6.4, p333). The 2014 226 
guideline states that when the term “must not be used” is provided in relation to a procedure then 227 
“the consequences of not following the recommendation could be extremely serious or potentially 228 
life threatening” (p106). The guide goes on to say that; “We use similar forms of words (for example, 229 
'Do not offer…') when we are confident that an intervention will not be of benefit for most patients” 230 
(p106). The use of the term “do not use” would seem to place the advice on SWI somewhere 231 
between no benefit for most patients (do not offer) and extremely serious consequences (must not 232 
be used). Whilst the NICE guidelines may not be absolute in terms of influencing practice they are 233 
likely to have a significant impact on maternity care practice. The NHS Litigation Authority expects 234 
health services to address practice standards and risk assessment to reduce insurance liabilities and 235 
national clinical guidelines would figure prominently in these processes (Carthey et al., 2011). It is 236 
quite plausible then that the language used in the NICE guidance impacts on the hospitals decision 237 
to introduce SWI or not, as the survey suggested only a very small number of hospitals were in the 238 
process of introducing SWI as a care option.  239 
The lack of access to uniform evidence based guidelines was cited by midwives as a significant 240 
barrier to the use of SWI in practice. The need for units who have implemented the procedure to 241 
develop individual practice guidelines may have resulted in variations in techniques that impact 242 
upon efficacy. For example, half of the midwives who use SWI did so using the subcutaneous layer 243 
but many also stated they injected less ( 0.1 – 0.3 most commonly reported) than the 0.5 mls that is 244 
usually advised when using this approach (Martensson & Wallin, 1999). The reduced volume of 245 
sterile water per injection may decrease the analgesic effect of the subcutaneous route. Midwives in 246 
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this survey who used the subcutaneous route were less likely to report SWI as being very effective or 247 
very reliable compared to those using the intradermal route which does employ volumes of 0.1 – 0.3 248 
mls per injection. A randomised controlled trial by Martensson and Wallin (1999) compared the 249 
intradermal to the subcutaneous technique and found no difference in analgesic effect measure by 250 
visual analogue pain scales or midwives perception of effectiveness. Similarly 47% of respondents 251 
reported that they administer the injections between contraction, whereas the Cochrane review 252 
(Derry et al., 2012) suggests that administration during a contraction is most commonly used to 253 
mitigate the brief but intense pain associated with the injections. A qualitative study of women’s 254 
experiences of SWI use in labour also reported that this was the preferred approach (Lee et al., 255 
2016).  256 
A large proportion (86%) of midwives responding to the survey indicated that they were interested 257 
in accessing more information about SWI and that online resources were the preferred format. This 258 
is similar to the view expressed by Australian midwives in a 2011 survey of SWI use (Lee et al., 2012). 259 
Providing education and training to a large workforce across a 24 hour service with clinical 260 
responsibilities competing for time presents challengers for healthcare education (Atreja et al., 261 
2008). Online courses have been shown to be effective in providing continuing education to health 262 
care professionals (Liyanagunawardena & Williams, 2014). Suitably tailored online resources have 263 
also been demonstrated as acceptable to health care providers irrespective of age, gender or degree 264 
of computer literacy (Atreja et al., 2008). This approach has been used successfully to provide SWI 265 
training to midwives in the UK and Australia using a web based resource developed by the first 266 
author.  267 
A small number of midwives in the study expressed the view that the administration of SWI may be 268 
unethical as it may only have a placebo effect. As a treatment, a placebo, derived from the Latin ‘I 269 
shall please’, may produce an analgesic effect through altering expectations and conditioning. The 270 
placebo effect involves a complex process of interactions between the participant and the clinician 271 
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which typically begins with a mutual desire for symptom change, perhaps influenced by varying 272 
degrees of empathy and reassurance (Finniss et al., 2010). Placebos may produce not only a 273 
neurobiological response through the release of endogenous opioids, but have also been 274 
demonstrated to reduce neurological activity in pain-sensitive areas of the brain, thereby altering 275 
the experience of pain at a physiological level (Wager et al., 2004). The effectiveness of a placebo 276 
would, to some extent, rely upon the expectation of the recipient to an effect. In a qualitative study 277 
of experiences of using SWI in labour women often reported no real expectation of effect from the 278 
procedure as it was ‘just water’ then expressed surprise when their back pain was relieved (Lee et 279 
al., 2016). This would suggest an analgesic effect from SWI that was not reliant upon any 280 
preconceived expectations.   281 
The study has a number of limitations. The sample is not random and cannot be considered 282 
representative of all UK midwives. Also we cannot accurately estimate the proportion of UK 283 
midwives who had the opportunity to, and actually did respond. The use of social media for the 284 
distribution of the survey may also influence the demographics of the respondents. For example in 285 
2016 32% of midwives in England (where 86% of participants reside) were over the age of 50 (Royal 286 
College of Midwives, 2016), whereas in this age bracket accounted for 18.1% of respondents. Both 287 
Facebook and Twitter usage is much more common in the under 50’s age bracket (Duggan & 288 
Brenner, 2013). Hence the overrepresentation of the under 50s age group in the sample may 289 
overestimate the overall use of SWI amongst UK midwives. It may also be that midwives using SWI 290 
were more likely to respond to the survey based on familiarity with the topic.  291 
 292 
Conclusion 293 
The main findings of the study were that the use of sterile water injections is not common in the UK 294 
but there is a desire amongst midwives to learn more about the procedure. The advice provided by 295 
the NICE guidelines to ‘not use SWI’ has limited the availability of the procedure as an analgesic 296 
13 
 
©2018 This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
option, however this review is not based on current evidence. The absence of evidence informed 297 
practice guidelines in the UK may also have resulted in variations to accepted techniques that could 298 
impact on the effectiveness of SWI where it is being offered. Access to online training materials 299 
would assist in disseminating a consistent technique that maximise the analgesic effect. The issues 300 
encountered in distributing the survey effectively on a national basis highlight the need for support 301 
for professional representative organisations to participate in research.  302 
    303 
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Table 1. Demographic characteristics of midwives participating in 
the study 
Participants n (%) 
Age, years,  (n=398)  
20 – 30 
31 – 40 
41 – 50 
51 – 60 
Over 60 
113 (28.4) 
110 (27.6) 
103 (25.9) 
65 (16.3) 
7 (1.8) 
  
Original Midwifery Qualification (n=397)  
Hospital certificate 
Bachelor of Midwifery 
Post Nursing registration Midwifery course 
Masters of Midwifery 
19 (4.8) 
263 (66.2) 
109 (27.4) 
6 (1.6) 
  
Employment (n=398)  
Part time 
Full time 
136 (34.2) 
262 (65.8) 
  
Model  of care / workplace setting (n=396)  
Alongside midwifery unit 
Free standing midwifery unit 
Homebirth 
76 (19.4) 
14 (3.5) 
37 (9.3) 
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Private group practice 
Private  practitioner 
Obstetric Unit 
Agency/Contract 
2 (0.5) 
5 (1.2) 
261 (65.9) 
1 (0.2) 
  
  
Years of experience as a midwife (n=397) 
(Mean (SD)                                    
12.2 (17.9) 
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Table 2 Characteristics of midwives using and not using SWI in 
practice 
Participants (n=398) Midwives 
using SWI in 
practice 
(n=72, 18%) 
Midwives  not 
using SWI in 
practice 
(n=326, 82.2%) 
Main  Clinical area n (%) n (%) 
Antenatal/Postnatal 
Birth Centre 
Community 
Group practice 
Homebirth 
Independent midwife 
Labour ward 
Management 
Neonatal Intensive Care 
Unit 
Research and Education  
Specialist Areas 
11 (2.7) 
12 (3.0) 
5 (1.2) 
1 (0.2) 
0 (0) 
0 (0) 
42 (10.5) 
1 (0.2) 
0 (0) 
0 (0) 
0 (0) 
50 (12.6) 
33 (8.3) 
67 (17.0)  
3 (0.8) 
3 (0.8) 
4 (1.0) 
147 (37.0) 
9 (2.3) 
2 (0.5) 
3 (0.8) 
5 (1.2) 
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Age    
20-30 years 
31 – 40  
41 – 50  
51 - 60  
Over 60  
23 (5.7) 
24 (6.0) 
15 (3.7) 
9 (2.2) 
1 (0.2)  
 
90 (22.6) 
86 (21.6) 
88 (22.1) 
56 (14.0) 
6 (1.5)  
Country of the UK   
         England 62 (15.6) 279 (70.1) 
         Northern Ireland 3 (0.7) 19 (4.7) 
         Scotland 3 (0.7)  17 (4.2) 
         Wales 0 13 (3.2) 
Geographical type    
City 34 (8.6) 182 (46.0) 
Town 37 (9.3) 129 (32.6) 
Rural community  1 (0.2) 12 (3.0)  
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Table 3 Midwives perceived effectiveness and 
reliability of sterile water injections. 
Effectiveness (n=57)                                           n (%) 
Very Effective 37 (64.9) 
Moderately effective 12 (21.0) 
Not very effective 3 (5.26) 
Rarely effective 5  (8.77) 
Reliability (n=58)                                                n (%)                         
Very reliable 36 (62.0) 
Moderately reliable 10 (17.2) 
Not very reliable 5 (8.6) 
Unreliable 7 (12.0) 
 
